-
Diagnostics World News | Connected diagnostics and care automation could remove one trillion dollars in annual global healthcare spending, or roughly 10% of the outlay in 2022, according to Ken Mayer, founder and CEO of Safe Health Systems, who presented yesterday at the Next Generation Dx Summit. The enabler may well be a digital health and diagnostic platform the company operates in partnership with the Mayo Clinic.
Aug 25, 2021
-
Diagnostics World News | Thanks to photoacoustics, a blend of modern-day ultrasound machines and lasers, physicians in the next decade could be using a routine imaging test to “hear” the sound signal of a future heart attack. As envisioned, photoacoustic imaging would likely serve as a complement to intravascular ultrasound (IVUS) or standard ultrasound by reporting on the whereabouts and inflammatory status of atherosclerotic plaque.
Aug 24, 2021
-
Diagnostics World News | For the benefit of laboratory and healthcare professionals, the American College of Medical Genetics and Genomics (ACMG) and Association for Molecular Pathology (AMP) published joint guidelines in 2015 aimed at standardizing terminology and the classification of sequence variants uncovered through genetic testing. Understandably, in the several years since then, there have been tremendous advances in this field of molecular diagnostics such as next-generation sequencing (NGS) technologies unlocking new opportunities to understand an individual’s unique genetic makeup. Armed with these insights, healthcare providers can personalize therapeutic options for their patients with genetic diseases, helping to manage or treat them altogether.
Aug 20, 2021
-
Diagnostic World News | Researchers at Massachusetts Institute of Technology have developed a urine-based molecular assay that can both reveal the presence of cancerous proteins and pinpoint a tumor’s location. The double-duty diagnostic nanosensor could one day be of clinical value in evaluating treatment response and long-term monitoring of tumor recurrence.
Aug 17, 2021
-
Diagnostics World News | The US Food and Drug Administration (FDA) in February issued an AI and Machine Learning Software as a Medical Device Action Plan, outlining the way forward for manufacturers seeking the agency’s approval for their innovative medical devices incorporating AI.
Aug 12, 2021
-
Diagnostics World News | As the coronavirus pandemic continues, new initiatives are emerging to help fend off future pandemics including the Pandemic Sciences Centre at the University of Oxford and the Centers for Research in Emerging Infectious Diseases, a global network investigating how and where viruses and other pathogens emerge from wildlife settings.
Aug 9, 2021
-
Diagnostics World News | InterVenn closes a series C for liquid biopsy assay for immune checkpoint inhibitor response prediction, Strata advances personalized minimal residual disease (MRD) assays, Lumos Diagnostics in Australia goes public, and more.
Aug 5, 2021
-
Diagnostics World | More COVID-19 tests prove accurate for the delta variant, NVIDIA’s Cambridge-1 supercomputer builds synthetic brain images, biobank and practice acquisitions, and FDA companion diagnostic approvals for Foundation Medicine.
Aug 3, 2021
-
Diagnostics World News | As more people become vaccinated, researchers are continuing to evaluate the duration of immunity and variations in an immune response among previously infected and non-infected people, using neutralizing antibodies as their metric. This growing body of information presents critical data about COVID-19 immunity that determines when and how individuals should protect themselves from the virus. Understanding immunity levels offers global solutions for ending the COVID-19 pandemic and addressing future health crises.
Aug 2, 2021
-
Diagnostics World News | Extrachromosomal DNA (ecDNA), circles of DNA outside the chromosomes but still within the nucleus of a cell, is believed to be an important but overlooked target in the treatment of amplification-driven tumors that have up to now been uniformly resistant to anti-cancer therapies. Boundless Bio is actively exploring the genes and cellular processes that underpin some crafty maneuvers of ecDNA using a precision medicine platform called Spyglass.
Jul 29, 2021
-
Diagnostics World News | Researchers with Singapore-based longevity startup Gero have used wearable sensor data and artificial intelligence to develop digital biomarkers of longevity, stress, and resilience. The novel GeroSense biological age acceleration model is being positioned as a practical, high-quality alternative to blood tests or genomic profiling for large-scale population health studies.
Jul 27, 2021
-
Diagnostics World News | The sources of health disparities are complex, and diagnostic testing is just one waystation on what is often an exhausting trek for many patients and their families. But today’s genetic tests may not be useful across ancestral groups.
Jul 26, 2021
-
Diagnostics World News | The board members of both Sema4 and CM Life Sciences voted this week to approve the special purpose acquisition company. The resulting combined company, Sema4 Holdings Corp, will commence trading of its shares of common stock and warrants on the Nasdaq Global Select Market under the ticker symbols "SMFR" and “SMFRW” today or Monday.
Jul 23, 2021
-
Diagnostics World News | Pacific Biosciences announced this morning that it has signed a definitive merger agreement under which it will acquire Omniome, a San Diego-based company developing a highly differentiated, proprietary short-read sequencing platform capable of delivering high accuracy.
Jul 20, 2021
-
Diagnostics World News | Systemic chronic inflammation—a universally strong signal of ill health associated with all nine hallmarks of aging and diseases that collectively represent the leading causes of disability and mortality worldwide—can now be measured by an inflammatory clock of aging (iAge) developed by investigators at the Stanford University School of Medicine and the Buck Institute for Research on Aging. It is the first “actionable clock” that predicts multimorbidity, frailty, immunological health, and chronic diseases of aging.
Jul 15, 2021
-
Diagnostics World News | Employers are testing for COVID-19 at noticeably higher levels in 2021 compared to late 2020, according to findings from a global business survey conducted by Arizona State University's College of Health Solutions and the World Economic Forum, along with support from the Rockefeller Foundation. Responses came from over 1,100 companies spanning more than 20 industry sectors and over 30 countries.
Jul 13, 2021
-
Diagnostics World News | A “silver lining” of COVID-19 is that it has ushered in a new era of diagnostic innovation within test manufacturing facilities and clinical and public health laboratories, producing in 18 months what would be a decade’s worth of progress in non-pandemic times. Near-universal focus on one common problem created new ways to work together, overcome gaps in resources, and develop novel point-of-care testing methods under intense time pressures, as will be explored during the upcoming Next-Gen Dx Summit.
Jul 8, 2021
-
Diagnostics World News | A team of researchers from Beijing Normal University in China has developed an artificial intelligence-based brain age prediction model to quantify deviations from a healthy brain-aging trajectory in patients with mild cognitive impairment. They hope the model will help earlier detection of cognitive impairment at an individual level.
Jul 6, 2021
-
Diagnostics World News | Insilico Medicine closes a Series C for AI-powered drug discovery, while other investments fuel microbiome-based diagnostics.
Jul 2, 2021
-
Diagnostics World News | What’s next for Biogen and Eisai; COVID updates from Thermo Fisher, New England Biolabs, and OraSure; new products from QIAGEN, InterVenn, Nuvo Group and more.
Jun 29, 2021